Acute dilatory and negative inotropic effects of homocysteine are inhibited by an adenosine blocker

Clinical and Experimental Pharmacology & Physiology
Richard H KennedyMarjan Boerma

Abstract

1. Previous studies have shown that homocysteine elicits acute negative inotropic and coronary vasodilatory effects in rat hearts. In addition, this earlier work suggested that the inotropic action is mediated via an endothelium-derived agent that is neither nitric oxide (NO) nor a cyclooxygenase product, while the coronary actions were found to be antagonized by the NOS inhibitor l-NNA. Current experiments, which utilized coronary-perfused rat hearts, were designed to determine if muscarinic or adenosine receptors are involved in these acute actions of homocysteine. 2. Left ventricular developed pressure was used as a measure of systolic function in electrically paced, Langendorff-perfused heart with coronary pressure being used to monitor coronary vascular tone. Acute effects of homocysteine (10-300 micromol/L) were examined in the presence and absence of 1 yen 10(-6) mol atropine or 7 yen 10(-5) mol 8-(p-sulfophenyl) theophylline (SPT), a non-selective adenosine receptor antagonist. 3. Atropine had no effect on either the inotropic or vascular actions of homocysteine. In contrast, SPT partially antagonized both actions of the amino acid with the antagonism of the vasodilation being much greater than its inhibition of the neg...Continue Reading

References

Jul 1, 1989·Progress in Cardiovascular Diseases·L BelardinelliR M Berne
Sep 1, 1985·Basic Research in Cardiology·S NeesE Gerlach
Sep 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·R F BrunsS H Snyder
Oct 4, 1995·JAMA : the Journal of the American Medical Association·C J BousheyA G Motulsky
Jul 1, 1996·The Journal of Clinical Investigation·J Loscalzo
Jul 4, 1997·The Journal of Biological Chemistry·G R UpchurchJ Loscalzo
Jul 24, 1997·The New England Journal of Medicine·O NygårdS E Vollset
Oct 6, 1997·British Journal of Pharmacology·I QuéréM M Loubatières-Mariani
Dec 3, 1999·Journal of Internal Medicine·O NygårdP M Ueland
Jun 8, 2001·Journal of Cardiovascular Pharmacology·Z Ungvari, A Koller
Jan 5, 2002·The New England Journal of Medicine·G SchnyderO M Hess
Mar 14, 2003·JAMA : the Journal of the American Medical Association·Ramachandran S VasanPeter W F Wilson
Apr 9, 2004·Journal of Cardiovascular Pharmacology·Arda TasatargilCengiz Turkay
Apr 10, 2004·American Journal of Physiology. Heart and Circulatory Physiology·Richard H KennedyJacob Joseph

❮ Previous
Next ❯

Citations

Sep 22, 2007·Current Heart Failure Reports·Venkataraman Rajaram, Jacob Joseph

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.